Abiopharma

NASDAQ symbol attribute type Security_Name was changed. Previous value: Mersana Therapeutics, Inc. - Common Stock. New value: Mersana Therapeutics, Inc. - Common Stock.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Mersana Therapeutics, Inc. - Common Stock.

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: CureVac N.V. - Ordinary Shares.

NASDAQ symbol attribute type Security_Name was changed. Previous value: CureVac N.V. - Ordinary Shares. New value: CureVac N.V. - Ordinary Shares.

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Mersana Therapeutics, Inc. - Common Stock.

Ionis partner GSK announces positive topline results from B-Well 1 and B-Well 2 Phase 3 studies for bepirovirsen, a potential first-in-class medicine for chronic hepatitis B

Innate Pharma - Number of Shares and Voting Rights of Innate Pharma as of December 31, 2025

Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia

Number of Shares and Voting Rights of Innate Pharma as of December 31, 2025

Praxis Precision Medicines, Inc. Announces Pricing of $575 Million Public Offering

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Director Turtle Cameron 🔴 sold 15.0K shares of Spyre Therapeutics, Inc. (SYRE) at $32.39 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Hurlburt Elizabeth 🔴 sold 10.9K shares of CorMedix Inc. (CRMD) at $12.16 Transaction Date: Jan 02, 2026 | Filing ID: 001938

Zelnick Kaufman Beth 🔴 sold 11.3K shares of CorMedix Inc. (CRMD) at $12.16 Transaction Date: Jan 02, 2026 | Filing ID: 001937